Although NRF2 is known to promote tumor progression in pancreatic cancer (14, 15), it has also been implicated in tumor suppression in certain gastrointestinal malignancies, including chemically induced gastric (35) and colon (36) cancers. This evidence concerns the gene NFE2L2 and neoplasm.